Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial. - Lee MJ; Cherrill LR; Zacharopoulou P; Collins S; Fumagalli M; Falaschetti E; Altaf M; Tipoe T; Godakandaarachi P; Fox J; Uriel A; Clarke A; et al. (The lancet. HIV, 2026)